Experts are questioning aspects of some of the Ebola guidelines that go beyond current Centers for Disease Control and Prevention (CDC) recommendations, especially those that call for suspending certain routine lab tests, according to an article on Infection Control Today.
A commentary in the journal Transfusion suggests that most individuals with suspected Ebola will have a fever due to another cause, and forgoing such testing may compromise patients' health more than any reduction in the risks to laboratory personnel.
The article says that all laboratory directors must work with infection control and safety experts to evaluate their hospital policies on potentially infectious patients to provide a safe environment.
Strategies for Success with Life Sciences and Healthcare Projects
Building Disaster Resilience Through Collaboration
Archer Acquires MemorialCare-Anchored Orange County Medical Office Portfolio
Life Sciences and Healthcare: Reshaping Institutional Design
Arnprior Regional Health Upgrades Building Controls to Improve IEQ